Following patient deaths in a lupus trial that led to the termination of that program, Kezar’s autoimmune candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback